SFRP5 and fatty liver disease: Regarding animal models, previous studies reported that SFRP5 is a protective adipokine for glucose tolerance, adipose inflammation, hepatic steatosis, and fibrosis, and its anti-inflammatory role is perturbed in animal models of obesity with T2DM [14,15,16].